MiR-29 mediates TGFβ1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts

Journal of Cellular Biochemistry

Volumn 114, Issue 6, 2013, Pages 1336-1342

  Yang, Tao ^a,b   Liang, Ying ^a   Lin, Qinlu ^a   Liu, Junwen ^c   Luo, Feijun ^a   Li, Xinhua ^d   Zhou, Hui ^a,b   Zhuang, Sheng ^a   Zhang, Hongliang ^e  

^a CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

^b CHANGSHA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Lung Fibrosis; miR 29; PI3K AKT; TGF 1

Indexed keywords

MICRORNA 29; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL LINE; CELL PROLIFERATION; COLONY FORMATION; EMBRYO; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PATHOGENESIS; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SYNTHESIS; UPREGULATION;

CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; DOWN-REGULATION; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; LUNG; MICRORNAS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84876270973     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24474     Document Type: Article

References (23)

1. Bartel DP,. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
2. Border WA, Noble NA,. 1994. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292.
3. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G,. 2005. Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 289: H982-H991.
4. Calin GA, Croce CM,. 2006. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 66: 7390-7394.
5. Campbell SE, Katwa LC,. 1997. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29: 1947-1958.
6. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J,. 1999. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: Involvement of Smad 3. J Invest Dermatol 112: 49-57.
7. Chu AS, Friedman JR,. 2008. A role for microRNA in cystic liver and kidney diseases. J Clin Invest 118: 3585-3587.
8. Chung AC, Huang XR, Meng X, Lan HY,. 2010. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21: 1317-1325.
9. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lü J,. 2011. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294.
10. Cutroneo KR, White SL, Phan SH, Ehrlich HP,. 2007. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 211: 585-589.
11. Fuentes-Calvo I, Blazquez-Medela AM, Eleno N, Santos E, Lopez-Novoa JM, Martínez-Salgado C,. 2012. H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. Am J Physiol Cell Physiol 302: C686-C697.
12. Lee CG, Cho S, Homer RJ, Elias JA,. 2006. Genetic control of transforming growth factor-beta1-induced emphysema and fibrosis in the murine lung. Proc Am Thorac Soc 3: 476-477.
13. Moore BB, Hogaboam CM,. 2008. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152-L160.
14. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N,. 2010. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220-229.
15. Park SY, Lee JH, Ha M, Nam JW, Kim VN,. 2009. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16: 23-29.
16. Saika S, Yamanaka O, Baba Y, Kawashima Y, Shirai K, Miyamoto T, Okada Y, Ohnishi Y, Ooshima A,. 2001. Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol 239: 234-241.
17. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS,. 2010. Non-coding RNAs: Regulators of disease. J Pathol 220: 126-139.
18. Thannickal VJ, Toews GB, White ES, Lynch JP, Martinez FJ,. 2004. Mechanisms of pulmonary fibrosis. Annu Rev Med 55: 395-417.
19. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S, 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
20. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA,. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363.
21. Uhal BD, Kim JK, Li X, Molina-Molina M,. 2007. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: Autocrine mechanisms in myofibroblasts and macrophages. Curr Pharm Des 13: 1247-1256.
22. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN,. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032.
23. Van Rooij E, Olson EN,. 2007. MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376.